Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2008
10/22/2008EP1981977A1 Production of polysialic acid containing glyconjugates using a self-priming polysialyltransferase
10/22/2008EP1981532A2 Epha2 bite molecules and uses thereof
10/22/2008EP1814902B1 Cyclosporine analogue
10/22/2008EP1375518B1 Anti-osteopontin antibody and use thereof
10/22/2008EP1311679B1 Method for inhibiting il-22 induced pap1
10/22/2008EP1189935B1 Extraction of integral membrane proteins
10/22/2008EP1017725B1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies
10/22/2008EP0828519B1 Recombinant viral vector system
10/22/2008EP0817835B1 Production of antibodies using cre-mediated site-specific recombination
10/22/2008EP0746612B1 Synthetic polynucleotides
10/22/2008EP0742825B1 Cloning and recombinant production of crf receptor(s)
10/22/2008CN101292042A Cancerous desease modifying antibodies
10/22/2008CN101292041A Cancerous desease modifying antibodies
10/22/2008CN101292040A Enzymatic conversion of oligopeptide amides to oligopeptide alkyl esters
10/22/2008CN101289686A Collagen protein in hair dye for reducing irritability of scalp and production method thereof
10/22/2008CN101289685A Process for preparing phosphopeptide non-phosphopeptide by hydrolyzing protein through enzyme
10/22/2008CN101289663A Process for preparing anti-hypertension polypeptides by enzymolysis of MRJP1 expression products of China honey bee
10/22/2008CN101289650A Expression process of heat shock protein Hsp16.3 of mycobacterium tuberculosis
10/22/2008CN101289512A Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/22/2008CN101289511A Multivalent antibodies and uses therefore
10/22/2008CN101289510A Anti-CD40 monoclonal antibody
10/22/2008CN101289507A Collagen protein and collagen polypeptides, preparation thereof and applications
10/22/2008CN101289506A Novel scavenger receptors
10/22/2008CN101289505A Bone marrow regeneration regulatory protein BRRG-2, encoding gene thereof and uses thereof
10/22/2008CN101289504A Bone marrow regeneration regulatory protein BRRG-1, encoding gene thereof and uses thereof
10/22/2008CN101289394A Process for abstracting chlorogenic acid and separating protein and small peptide form sunflower meal
10/22/2008CN100427506C Process for preparation of polypeptides of interest from fusion polypeptides
10/22/2008CN100427505C Receptor DR5 monoclonal antibody (AD5-10) resisting human tumor necrosin related apoptosis inducing ligand and its prepn and use
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439328 Tctex-1-related polypeptides
10/21/2008US7439327 Stem cell factor-like proteins and uses thereof
10/21/2008US7439325 PRO6001 polypeptides
10/21/2008US7439225 Culturing Rhodococcus; antitubercular agents; side effect reduction
10/21/2008US7439224 Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
10/21/2008US7439050 Corynebacterium glutamicum genes encoding diaminopimelate epimerase
10/21/2008US7439043 Polyoxyethylene glycol moiety covalently joined to a sugar moiety of uridine-5'-diphosphate galactose; cell-free, in vitro method of remodeling an anti-tumor necrosis factor (TNF) alpha peptide; rheumatoid arthritis
10/21/2008US7439039 novel forms of serotonin transporter that lacks high affinity recognition of specific serotonin reuptake inhibitors; novel serotonin transporter molecules that lack a conventional mode of antagonism; drug screening; host cell expressing novel transporter
10/21/2008US7439038 Method for producing L-amino acid using methylotroph
10/21/2008US7439037 Protein gene expression; high density culture
10/21/2008US7439034 Alginases, systems containing alginases and methods of cloning, purifying and/or utilizing alginases
10/21/2008US7439025 Antibodies binding a gamma carboxyglutamic acid displaying epitope
10/21/2008US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
10/21/2008US7438911 Antibody against human insulin-like growth factor
10/21/2008US7438908 Antitumor agents
10/21/2008US7438906 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
10/21/2008CA2495581C Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes
10/21/2008CA2426127C Method for producing virus rna polymerase
10/21/2008CA2232242C Long wavelength engineered fluorescent proteins
10/21/2008CA2220226C Improved methods for transfecting t cells
10/21/2008CA2162361C Antisense oligonucleotides which combat aberrant splicing and methods of using the same
10/21/2008CA2042064C C-erbb-2 external domain:gp75
10/20/2008CA2626423A1 Detection of primary infections with pathogens
10/16/2008WO2008124170A2 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES
10/16/2008WO2008123622A1 Modified microorganism
10/16/2008WO2008123607A1 Method for production of dipeptide
10/16/2008WO2008123033A1 Method for production of proteolytic product containing branched amino acid at high content
10/16/2008WO2008122550A2 Pulverizer and corresponding method for preparing a biological sample for processing
10/16/2008WO2008122434A1 Bis-met histones
10/16/2008WO2008094197A3 Chimeric influenza virus-like particles
10/16/2008WO2008088548A3 Disintegrin variants and pharmaceutical uses thereof
10/16/2008WO2008070229A3 Detection of pathogenic aggregates of protein in a sample by homologous elisa
10/16/2008WO2008063493A3 Compositions and methods related to toll-like receptor-3
10/16/2008WO2008030367A3 Selective myostatin inhibitors
10/16/2008WO2008005847A3 Method of producing factor viii proteins by recombinant methods
10/16/2008WO2007133373A3 TNF-α VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-α
10/16/2008WO2007120932A3 Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms
10/16/2008WO2007117505A3 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
10/16/2008WO2007109035A3 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
10/16/2008WO2007103469A3 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/16/2008WO2007102872A3 Compositions and methods related to controlled gene expression using viral vectors
10/16/2008WO2007089873A3 Fermentation process for continuous plasmid dna production
10/16/2008WO2007087053A3 Bmp-7 variant compositions, methods and uses
10/16/2008WO2006138324A3 Treponema pallidum antigens for vaccine development and diagnostic tests
10/16/2008WO2006036613A3 Mracs as modifiers of the rac pathway and methods of use
10/16/2008WO2005003319A3 Glucanases, nucleic acids encoding them and methods for making and using them
10/16/2008US20080255343 Chimeric antibodies
10/16/2008US20080255342 Protein purification method
10/16/2008US20080255210 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system
10/16/2008US20080255045 Modified FGF-21 Polypeptides and Their Uses
10/16/2008US20080255040 Polypeptide with amino acid sequences including exogenous glycosylated sequences; libraries
10/16/2008US20080255026 Glycopegylated Factor Ix
10/16/2008US20080254515 Fermentative Production of Organic Compounds
10/16/2008US20080254514 Using transgenic eukaryotic cells as bioreactors for propagation of factor VII polypeptide
10/16/2008US20080254513 Cell Culture Medium
10/16/2008US20080254512 Hybrid immunoglobulins with moving parts
10/16/2008US20080254511 Process for the fermentative production of proteins
10/16/2008US20080254510 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
10/16/2008US20080254509 Increased purine/pyrimidine bias; nucleotide-diphospho-sugars biosynthesis
10/16/2008US20080254508 Nucleotide sequences coding erythromycin polyketide synthase comprising glycolyl and ethanolamine subunits; bactericides, fungicides, antitumor and immunosuppressive agents; directed protein evolution
10/16/2008US20080254507 Multimeric human immunodeficiency viricidal agent
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254505 Using microbial endopeptidase to convert beta-lactoglobulin and alpha-lactalbumin into dairy products
10/16/2008US20080254466 Heregulin-like Factor
10/16/2008US20080254048 He4 monoclonal antibodies and methods for their use
10/16/2008US20080254034 Microbial membrane protein for use in diagnosis, prevention and treatment of gramnegative bacterial infection
10/16/2008US20080254032 Colony stimulating bfcator specific monoclonal antibody for use in diagnosis, prevention and treatment of infcetion, cell proliferative, inflammatory, autoimmune, arthritic, skin, respiratory and nervous system disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254024 Anti-ephb2 antibodies and methods using same
10/16/2008US20080254021 Tie1-binding ligands
10/16/2008US20080254020 Protein fusions comprising immunoglobulin regions exhibiting improved bioefficacy in multidose administration for use in treatment of infection, cell proliferative, autoimmune and inflammatory disorders
1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 1125